198 Torsemide vs. furosemide plus metolazone for symptomatic chronic heart failure

Saturday, April 25, 2009
Elizabeth J. Greenhalgh, Pharm.D. , University of Illinois at Chicago Medical Center, Chicago, IL
Vicki L. Groo, Pharm.D. , University of Illinois at Chicago Medical Center, Chicago, IL
Thomas Stamos, M.D. , University of Illinois at Chicago, College of Medicine, Chicago, IL
Robert J. DiDomenico, Pharm.D. , University of Illinois at Chicago, Chicago, IL